vanflyta
daiichi sankyo europe gmbh - quizartinib dihydrochloride - leukémia, mieloid - antineoplastic agents, protein kinase inhibitors - vanflyta is indicated in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by vanflyta single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia (aml) that is flt3-itd positive.
clindamycin kabi 150 mg/ml oldatos injekció / koncentrátum oldatos infúzióhoz
fresenius kabi hungary kft. - clindamycin -
cidoclar 250 mg filmtabletta
teva magyarország zrt. - klaritromicin -
domperidon-ep 10 mg tabletta
extractum-pharma zrt. - domperidon -
flucohexal 50 mg kemény kapszula
hexal ag - flukonazol -
leflokin 500 mg filmtabletta
teva gyógyszergyár zrt. - levofloxacin -
lertazin 5 mg filmtabletta
krka d.d., - levocetirizine -
levoxa 250 mg filmtabletta
actavis group ptc ehf. - levofloxacin -
levoxa 500 mg filmtabletta
actavis group ptc ehf. - levofloxacin -
marfarin 5 mg tabletta
viatris ltd. - warfarin -